Status:
UNKNOWN
Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Cinematics and Cost-utility
Lead Sponsor:
Töölö Hospital
Conditions:
Arthritis
Thumb Osteoarthritis
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
A project aiming to promote evidence based practice when treating thumb basal joint (CMC I) arthritis. We will aim to: 1) provide the minimal clinical difference of two general outcome instruments, 2)...
Eligibility Criteria
Inclusion
- Eaton-Glickel \>2 arhritis
- Symptom duration \>3 months
- Pain VAS \>30mm
- No significant comorbidities, ASA I-II
- Fluent in Finnish language
Exclusion
- Eaton-Glickel \<2
- Duration of symptoms \<3 months
- VAS \<30mm
- ASA \>II
- Inflammatory joint disease
- Systemic corticosteroid or immunomodulatory medication
- Upper limb symptoms not explained with CMC I artritis
- Heavy smoking (\> 20 cigarettes per day)
- Alcohol or drug abuse
- Neurological condition affecting upper limb function
- Other ipsilateral upper limb condition requiring surgery
Key Trial Info
Start Date :
March 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04826380
Start Date
March 29 2021
End Date
April 1 2025
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Töölö Hospital (Helsinki University Hospital)
Helsinki, Finland